Terms: = Bone cancer AND HNRNPA2B1, ENSG00000122566, SNRPB1, RNPA2, HNRPB1, HNRPA2, HNRNPB1, HNRNPA2, 3181 AND Treatment
4 results:
1. Spinal lesions in multiple myeloma: Primary bone tumors with distinct prognostic factors.
Ly R; Terrier LM; Cognacq G; Benboubker L; Destrieux C; Velut S; Zemmoura I; Francois P; Aggad M; Amelot A
Surg Oncol; 2023 Jun; 48():101927. PubMed ID: 36966661
[TBL] [Abstract] [Full Text] [Related]
2. Novel siRNA formulation to effectively knockdown mutant p53 in osteosarcoma.
Kundu AK; Iyer SV; Chandra S; Adhikari AS; Iwakuma T; Mandal TK
PLoS One; 2017; 12(6):e0179168. PubMed ID: 28636657
[TBL] [Abstract] [Full Text] [Related]
3. Safety and activity of trastuzumab-containing therapies for the treatment of metastatic breast cancer: our long-term clinical experience (GOIM study).
Adamo V; Franchina T; Adamo B; Ferraro G; Rossello R; Maugeri SaccĂ M; Scibilia C; Valerio MR; Russo A
Ann Oncol; 2007 Jun; 18 Suppl 6():vi11-5. PubMed ID: 17591801
[TBL] [Abstract] [Full Text] [Related]
4. Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma.
Nanus DM; Garino A; Milowsky MI; Larkin M; Dutcher JP
Cancer; 2004 Oct; 101(7):1545-51. PubMed ID: 15378501
[TBL] [Abstract] [Full Text] [Related]